ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.54
0.06%
US Tech 100
17,844.00
0.68%
S&P 500
5,246.68
0.48%
US Dollar vs CAD
1.36495
-0.03%
Bitcoin
61,674.78
0.21%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/14/20248:51PMPR Newswire (US)Industrial Filtration Market size is set to grow by USD 11400.65 mn from 2024-2028, increasing number of oil refineries to boost the market growth, Technavio
05/14/20248:30PMPR Newswire (US)Rogers-O'Brien Construction Named Winner in the Mid-Sized Business Category of Fast Company's 2024 World Changing Ideas Awards
05/14/20248:23PMPR Newswire (Canada)Genesis Reports Voting Results of Election of DirectorsTSX:GDCGenesis Land Development Corp
05/14/20248:21PMPR Newswire (US)Mason Capital Announces Tender Offer for Any and All of (i) the Outstanding American Depositary Shares (the "ADSs"), each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the "Ordinary Shares") for a Purchase Price of $437.
05/14/20248:13PMPR Newswire (US)Mason Capital Announces Tender Offer for Any and All of (i) the Outstanding American Depositary Shares (the "ADSs"), each representing 4,000 Ordinary Shares, Nominal Value 0.01 DKK of Forward Pharma A/S (the "Ordinary Shares") for a Purchase Price of $437.
05/14/20248:00PMPR Newswire (US)Casio to Release G-SHOCK-Surfrider Foundation Collaboration
05/14/20247:30PMPR Newswire (US)BRAEMAR HOTELS & RESORTS UPDATES STOCKHOLDERS THAT 'ACTIVIST' BLACKWELLS CAPITAL'S ATTEMPTED WITHHOLD PROXY CAMPAIGN AT ASHFORD TRUST HAS FAILEDNYSE:BHRBraemar Hotels and Resorts Inc
05/14/20247:30PMPR Newswire (US)Tianma showcasing wide range of new display products and prototype technologies at Display Week 2024
05/14/20247:25PMPR Newswire (US)ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY RESULTS OF ITS 2024 ANNUAL MEETING OF STOCKHOLDERS 'ACTIVIST' BLACKWELLS EFFORTS THWARTEDNYSE:AHTAshford Hospitality Trust Inc
05/14/20247:23PMPR Newswire (Canada)Sagicor Financial Reports First Quarter 2024 Results and Announces Meeting of Shareholders, Availability of 2023 Management Information Circular, Annual Report and Annual Information FormTSX:SFCSagicor Financial Company Ltd
05/14/20247:20PMPR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le mercredi 15 mai 2024
05/14/20247:16PMPR Newswire (US)PDS Health Named Among The Civic 50 National Honorees by Points of Light
05/14/20247:12PMPR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Wednesday, May 15, 2024
05/14/20247:00PMPR Newswire (US)The Fight for Elderym Begins Today as Guild of Guardians Launches on iOS and Android
05/14/20246:46PMPR Newswire (Canada)Déclaration du premier ministre concernant le décès d'Alice Munro
05/14/20246:44PMPR Newswire (Canada)Statement by the Prime Minister on the passing of Alice Munro
05/14/20246:35PMPR Newswire (US)NEW: 2024 Flavor & Product Trends Announced At Sweets & Snacks Expo
05/14/20246:34PMPR Newswire (Canada)Andlauer Healthcare Group Announces Intention To Commence Substantial Issuer BidTSX:ANDAndlauer Heathcare Group Inc
05/14/20246:30PMPR Newswire (US)Electrophysiology Market size is set to grow by USD 6.09 bn from 2024-2028, increasing incidence of target diseases and electrophysiology procedures to boost the market growth, Technavio
05/14/20246:30PMPR Newswire (US)Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track StatusNASDAQ:BIIBBiogen Inc
05/14/20246:30PMPR Newswire (Canada)Andréane Frenette-Vallières reçoit le Prix du CALQ - Artiste de l'année en Montérégie
05/14/20246:16PMPR Newswire (Canada)Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Indigo Shareholders Approve Arrangement with TrilogyTSX:IDGIndigo Books and Music Inc
05/14/20246:08PMPR Newswire (Canada)Advantage Announces Annual General and Special Meeting Voting Results on Election of DirectorsTSX:AAVAdvantage Energy Ltd
05/14/20246:01PMPR Newswire (US)New Chandler Good Government Index Shows Russian Government In Steep Decline, As The Country Struggles Under The Strains Of Putin's War
05/14/20246:00PMPR Newswire (US)Helping Men Through the Complex Journey of Loss After Becoming a Widower
05/14/20246:00PMPR Newswire (US)LG Display Unveils Newest Next-generation OLED Technologies at SID Display Week 2024NYSE:LPLLG Display Co Ltd
05/14/20246:00PMPR Newswire (US)UST to Train Over 25,000 Employees in Generative AI Technologies
05/14/20245:52PMPR Newswire (Canada)Bonterra Energy Announces First Quarter 2024 ResultsTSX:BNEBonterra Energy Corp
05/14/20245:51PMPR Newswire (US)Vanguard Announces Appointment of Salim Ramji as New CEO
05/14/20245:51PMPR Newswire (Canada)Surge Energy Inc. Announces Annual General Meeting Voting ResultsTSX:SGYSurge Energy Inc

Your Recent History

LSE
0H79
Arca Biopharma
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved